ResMed is riding the wave of a data and healthcare revolution, while also launching its own “revolutionary” new product, chief executive Mick Farrell says, after handing down a strong set of quarterly ...

The 62-year-old administrative law judge has Type 1 diabetes and needs the medication to live. The pharmacist ...

Among patients who took at least two doses of medication, GLP-1 receptor agonists were associated with a significantly lower ...

Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

The company provided clear evidence that it has plenty of resources to continue developing a potential blockbuster drug.

Some influencers are calling protein "nature's Ozempic." But can protein naturally stimulate your GLP-1 levels just like a ...

Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's ...

Though Lilly has been in the spotlight for the success of its GLP-1 drugs, the pharma giant has also been investing in a corporate brand campaign to boost its overall reputation.

New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...